Ruben Agresott
Hospital Universitario HM Sanchinarro, Universidad San Pablo CEU
Papers
2
Total Citations
47
H-Index
2
About
Dr. Ruben Agresott is a leading figure in minimally invasive surgical oncology, with a focused expertise in robotic-assisted abdominal surgeries and their cost-effectiveness. His major contributions lie in rigorously comparing robotic techniques against traditional laparoscopic and open approaches for complex procedures. Notably, his 2020 case-matched study on robotic-assisted right colectomy, which has garnered 34 citations, demonstrated that the robotic approach is not only safe and feasible but also offers comparable perioperative outcomes to laparoscopy while proving to be a cost-effective alternative. Expanding this line of inquiry, Dr. Agresott conducted a pivotal comparative cost-effectiveness study on robotic versus open surgical enucleation for pancreatic tumours. This 2022 work, cited 13 times, addressed a critical gap in the literature by providing the first detailed data on perioperative outcomes for the minimally invasive robotic technique in this challenging context. Through these high-impact analyses, Dr. Agresott has provided surgeons and healthcare systems with essential evidence to guide the adoption of robotic surgery, balancing clinical efficacy with economic viability.
Research Focus
Key Achievements
Top Papers
- 1
- 2